MedPath

A study to evaluate exposure to selected smoke constituents when using heated tobacco products

Not Applicable
Conditions
Smokers
Registration Number
JPRN-UMIN000041539
Lead Sponsor
JAPAN TOBACCO INC.
Brief Summary

On Day 5, significant reductions in most biomarkers of exposure (BoE) relative to the combustible cigarettes (CC) group were observed after switching to heated tobacco products. No changes in BoE were observed between baseline and Day 5 in the CC group. Significantly, the magnitude of the reduction in exposure to most of the selected harmful and potentially harmful constituents (HPHCs) observed in the heated tobacco product groups was close to that observed in the stopped smoking (SS) group.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
93
Inclusion Criteria

Not provided

Exclusion Criteria

-Subjects who have used tobacco products other than commercial cigarettes (i.e. heated tobacco products, hand-rolled cigarettes, cigarillos, cigars, pipes, snuff tobacco, chewing tobacco, etc.) within one week before screening -Pregnant or lactating women or women who may be pregnant -Employed by the tobacco industries, CRO or clinical facility etc.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The difference of biomarkers of exposure to selected smoke constituents between the investigational groups
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath